XENO (Xeno Transplants) ROCE %: -500.00% (As of Mar. 2008)


What is Xeno Transplants ROCE %?

Xeno Transplants XENO ROCE % is -500.00% as of Mar. 2008.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Xeno Transplants's annualized ROCE % for the quarter that ended in Mar. 2008 was -500.00%.

Xeno Transplants  (OTCPK:XENO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Xeno Transplants ROCE % Related Terms

Xeno Transplants ROCE % Historical Data

* Premium members only.

The historical data trend for Xeno Transplants's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xeno Transplants ROCE % Chart

Xeno Transplants Annual Data
Trend Jun05 Jun06 Jun07
ROCE %
-97.06 -427.27 -68.45

Xeno Transplants Quarterly Data
Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -47.89 -98.44 -161.37 -298.25 -500.00

Xeno Transplants ROCE % Calculation

Xeno Transplants's annualized ROCE % for the fiscal year that ended in Jun. 2007 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2007 )  (A: Jun. 2006 )(A: Jun. 2007 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2007 )  (A: Jun. 2006 )(A: Jun. 2007 )
=-0.128/( ( (0.001 - 0.013) + (0.641 - 0.255) )/ 2 )
=-0.128/( (-0.012+0.386)/ 2 )
=-0.128/0.187
=-68.45 %

Xeno Transplants's ROCE % of for the quarter that ended in Mar. 2008 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2008 )  (Q: Dec. 2007 )(Q: Mar. 2008 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2008 )  (Q: Dec. 2007 )(Q: Mar. 2008 )
=-0.44/( ( (0.961 - 0.818) + (1.079 - 1.046) )/ 2 )
=-0.44/( ( 0.143 + 0.033 )/ 2 )
=-0.44/0.088
=-500.00 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2008) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -500.00% mean?
Xeno Transplants (XENO) has a ROCE % of -500.00% as of Mar. 2008.
Is Xeno Transplants' ROCE % too high?
Xeno Transplants' current ROCE % is -500.00%.
How does Xeno Transplants' ROCE % compare to PRTX and GWSN?
Xeno Transplants' ROCE % of -500.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Xeno Transplants's current ROCE % is -500.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xeno Transplants stock overvalued right now?
Xeno Transplants (XENO) has a current ROCE % of -500.00%. The current ROCE % is -500.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Xeno Transplants (XENO), the current ROCE % is -500.00% as of Mar. 2008. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Xeno Transplants Business Description

Address 143 Gardner Road, Brookline, MA, USA, 02445
Xeno Transplants Corp is a bio-technology research and development company, which intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources.